CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health DAC Amortization Expense: $91M in Q4 2025, up 11.0% from a year earlier. That is the highest of the 16 quarters on record here.
Latest, Q4 2025
91
Period ended Dec 31, 2025
Change on a year earlier
+11.0%
82 in Q4 2024
History
16 quarters
Since Q1 2022
Sources
2
Documents cited below
Where the Q4 2025 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: CVS SEC 10-K (XBRL us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Cvs Health DAC Amortization Expense ($M), quarterly Q1 2022–Q4 2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/dac-amortization
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.